Mole News and Research

RSS

Growth-braking tumor-suppressor gene slows growth of childhood brain tumors

Johns Hopkins researchers have found a likely explanation for the slow growth of the most common childhood brain tumor, pilocytic astrocytoma. Using tests on a new cell-based model of the tumor, they concluded that the initial process of tumor formation switches on a growth-braking tumor-suppressor gene, in a process similar to that seen in skin moles.

24 Jun 2011

Experts help raise awareness about dangers of melanoma in the U.S.

San Diego is one of the top 10 sunniest cities in the United States. Even when "June Gloom" clouds our skies, the sun is still very powerful. With that in mind, experts with UC San Diego Moores Cancer Center are helping raise awareness of the dangers of melanoma, the most serious type of skin cancer.

21 Jun 2011

Dermatologists to provide free melanoma screenings at Loyola Center for Health on May 20

During a free health fair at work that offered screenings for skin cancer, Joan Rojek decided on a whim to have a dermatologist examine some odd-looking blemishes on her arm.

10 May 2011

Skin cancer prevention tips for anglers

If you love fishing and want to enjoy it well into your senior years then don't mess around with the sun. That's the advice for the 1 million Minnesotans who are expected to hit the water on Saturday for Minnesota's Fishing Opener from a leading Edina plastic and reconstructive surgeon who has treated hundreds of patients over the course of his 15-year career for skin cancer and melanoma.

10 May 2011

Dactinomycin more effective for low-risk gestational tumor treatment

A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.

26 Apr 2011

Longer looks: Tommy Thompson on Medicare; Was WSJ Pulitzer undeserved?; IPAB and cost cutting

The law contains Medicare cuts, but the savings achieved are then used to pay for new federal spending, such as the Medicaid expansion and new subsidies to purchase health care in state-based exchanges.

22 Apr 2011

Protecting skin from sun's ultraviolet radiation is best way to avoid potential skin problems

Summertime means plenty of fun in the sun for many. "I would burn on Saturday and Sunday, peel by Wednesday and be back on the water by the next Saturday doing the same thing," says Thomas Randall, a man in his 70s who spent much of his youth at a lake or a beach trying to tan a pale complexion. But countless hours of sun exposure have taken a toll on his skin, and he now needs regular examinations to search for pre-cancerous moles.

7 Apr 2011

More than 900 young Britons diagnosed with the deadliest form of skin cancer each year

Each day more than two people under 35 in Britain are diagnosed with malignant melanoma - the deadliest form of skin cancer - according to new figures from Cancer Research UK.

6 Apr 2011

Zebrafish model of human melanoma reveals new cancer gene

Looking at the dark stripes on the tiny zebrafish you might not expect that they hold a potentially important clue for discovering a treatment for the deadly skin disease melanoma. Yet melanocytes, the same cells that are are responsible for the pigmentation of zebrafish stripes and for human skin color, are also where melanoma originates.

24 Mar 2011

Professor develops optical technology that can detect, examine skin lesions

University of Rochester optics professor Jannick Rolland has developed an optical technology that provides unprecedented images under the skin's surface.

20 Feb 2011

Vascular birthmarks can cause concern for parents: Dermatologists

Vascular birthmarks, which occur in nearly 10 percent of all infants at birth or within the first few weeks of life, can cause concern for parents particularly if they are large or in a cosmetically important area. The decision to treat a birthmark is one that parents should make with a dermatologist, who can determine the type of birthmark and whether or not it poses any potential risks in the future.

5 Feb 2011

Painless, noninvasive biopsies with smart laser technology

Biopsies in the future may be painless and noninvasive, thanks to smart laser technology being developed at Michigan State University.

1 Feb 2011

New study shows biomarker test can aid in early, precise diagnosis of melanoma

A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.

24 Jan 2011

Women’s tears dampen men’s libido: Study

New research confirms an age old fear – men are truly turned off if the woman sheds tears. The researchers found that men who smelled the tears of weeping women produced less testosterone and found female faces less arousing.

10 Jan 2011

Low incentive fails to 'switch off' brain regions involved in mind-wandering among ADHD children

Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have difficulty in concentrating. The study, by experts at The University of Nottingham, may explain why parents often say that their child can maintain concentration when they are doing something that interests them, but struggles with boring tasks.

7 Jan 2011

Scientists discover that skin cancer can spread to lungs through cell blocking activity

CANCER RESEARCH UK-funded scientists have discovered that skin cancer can spread to the lungs when a gene in an important cell communication pathway is blocked. The research is published in Cancer Cell.

6 Jan 2011

Researchers find new light-activated platinum-based compound to kill cancer cells

When it comes to health care blue lights, are usually most useful on the top of ambulances but now new research led by the University of Warwick has found a way to use blue light to activate what could be a highly potent platinum-based cancer treatment.

10 Dec 2010

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.

8 Dec 2010

Experts suggest measure to raise awareness about skin cancer among retired population

Failure to get moles and skin changes checked out by a doctor has contributed to a steep rise in deaths from malignant melanoma among pensioners, experts warned today (Tuesday).

1 Dec 2010

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.